Today artificial intelligence (AI), machine learning (ML), deep learning (DL) and natural language processing (NLP) are all technologies that have become a part of the fabric of enterprise IT. However, solutions providers and end-users often use these terms interchangeably. Even though there can be significant conceptual overlaps, there are also important distinctions between these key technologies.
Increasingly, the value of AI in drug discovery is determined not by model complexity alone, but by how well biological context is preserved across data, computation, and experimentation. Platforms such as MindWalk reflect this shift—prioritizing biological fidelity, traceability, and integration with experimental workflows so that computational insight remains actionable as discovery programs scale.
Here’s a quick overview of the definition and scope of each of these terms.
The term AI has been around since the 1950s and broadly refers to the simulation of human intelligence by machines. It encompasses several areas beyond computer science including psychology, philosophy, linguistics and others.
AI can be classified into four types, from simplest to most advanced, as reactive machines, limited memory, theory of mind and self-awareness.
The concept of AI is continuously evolving based on the emergence of technologies that enable the most accurate simulation of human intelligence. Some of those technologies include ML, DL, and artificial neural networks (ANN) or simply neural networks (NN).
Here’s the TL;DR before we get into each of these concepts in a bit more detail: If AI’s objective is to endow machines with human intelligence, ML refers to methods for implementing AI by using algorithms for data-driven learning and decision-making. DL is a technology for realizing ML and expanding the scope of AI. Reinforcement Learning (RL), or evaluation learning, is an ML technique. And deep reinforcement learning (DRL) combines DL and RL to realize optimization objectives and advance toward general AI.
SOURCE: Researchgate
ML is a subset of AI that involves the implementation of algorithms and neural networks to give machines the ability to learn from experience and act automatically.
ML algorithms can be broadly classified into three categories.
DL is a subset of ML where models built on deep neural networks work with unlabeled data to detect patterns with minimal human involvement. DL technologies are based on the Theory of Mind type of AI where the idea is to simulate the human brain by using neural networks to teach models to perceive, classify, and analyze information and continuously learn from these interactions.
DL techniques can be classified into three major categories:
Deep Reinforcement Learning (DRL) combines RL with DL techniques to solve challenging sequential decision-making problems. Because of its ability to learn different levels of abstractions from data, DRL is capable of addressing more complicated tasks.
NLP is the branch of AI that deals with the training of machines to understand, process, and generate language. By enabling machines to process human languages, NLP helps streamline information exchange between human beings and machines and opens up new avenues by which AI algorithms can receive data. NLP functionality is derived from cross-disciplinary theories from linguistics, AI and computer science.
There are two main types of NLP algorithms, rules-based and ML-based. Rules-based systems use carefully designed linguistic rules whereas ML-based systems use statistical methods. NLP also consists of two core subsets, natural language understanding (NLU) and natural language generation (NLG).
NLU enables computers to comprehend human languages and communicate back to humans in their own languages. NLG is the use of AI programming to mine large quantities of numerical data, identify patterns and share that information as written or spoken narratives that are easier for humans to understand.
Natural language processing (NLP) systems generally fall into two broad categories: rules-based and deep learning-based.
Rules-based systems rely on expert-defined heuristics and pattern matching, offering transparency and interpretability. However, they tend to be brittle and limited in scalability across biomedical domains.
In contrast, deep learning models—including transformers like BioBERT and SciSpacy—automatically learn contextual relationships from large biomedical corpora. These models serve as powerful biomedical text mining tools, offering greater flexibility and accuracy in processing complex, ambiguous language found in clinical narratives, scientific publications, and electronic health records (EHRs).
Many life sciences applications now favor hybrid pipelines that combine the precision of rule-based systems with the adaptability of deep learning—balancing interpretability and performance in production settings.
This overview outlines the key technological acronyms shaping today’s discussions around AI-driven drug discovery. You can also explore how AI/ML technologies are are advancing Intelligent Bioinformatics and autonomous drug discovery and the importance and challenges of NLP in biomedical research.
Curious about NLP? Dive deeper into our article for further exploration.